Fogarty International Center

Fogarty International Center

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities NIH funding opportunities focusing on global health and foreign collaboration. Fogarty HIV Research Training Application Receipt Date(s): August 20, 2019; August 20, 2020; August 20, 2021 More information about the Fogarty HIV Research Training Program. Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) (PAR-19-283) Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) (PAR-19-284) Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11Clinical Trials Not Allowed) (PAR-19-285) Request for Information: Seeking Feedback on Research Priorities from SCI 2020: Launching a Decade of Disruption in Spinal Cord Injury (SCI) Research (NOT-NS-19-060) NIH is seeing feedback on spinal cord injury research priorities, including input on how research and research capacity building in priority areas may be adopted in low-resource settings, including low- and middle-income countries. Submit responses through July 30, 2019. NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply. NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed) (PAR-19-281) Application Receipt Date(s): September 13, 2019, and more PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional) (RFA-DA-20-013) Application Receipt Date(s): November 8, 2019 Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (PAR-19-282) Application Receipt Date(s): October 10, 2019; and more Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) (PAR-19-279) and (R21 Clinical Trial Optional) (PAR-19-280) Application Receipt Date(s): July 15, 2019; November 15, 2019; July 15, 2020; November 15, 2020 NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity. Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) (RFA-DA-20-017) and (R43/R44 Clinical Trial Optional) (RFA-DA-20-018) Application Receipt Date(s): July 29, 2019 Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional) (RFA-DA-20-020) and (R43/R44 - Clinical Trial Optional) (RFA-DA-20-021) Application Receipt Date(s): August 7, 2019 Information related to opportunities from other organizations focusing on global health and foreign collaboration. Strengthening Antenatal Care (ANC) and Postnatal Care (PNC) Service Delivery and Innovations is a part of the Bill and Melinda Gates Foundation Maternal, Newborn and Child Health (MNCH) strategy. Concept note deadline: June 10, 2019

Funding News

NIH funding news that may be relevant to global health researchers.

• Guidance on Posting Informed Consent Forms for NIH-Funded Clinical Trials (NOT-OD-19-110)
• NIGMS-Managed HIV/AIDS Research Portfolio Transitioning to NIAID (NOT-GM-19-039)
• Request for Information (RFI): Inviting Comments on Non-Human Animal Models of Substance Use Disorders (NOT-DA-19-036)
• Request for Information (RFI): The NINDS is Soliciting Input on Enhancing Neuroscience Research at Institutions with Emerging Neuroscience Programs (NOT-NS-19-059)
• Notice of Special Interest for Small Business Research in Genomics (NOT-GM-19-041)

Upcoming Deadlines

• BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa from NHLBI
  Updated application deadline: June 11, 2019
• Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions from NHBLI and NINDS
  Application deadline: July 8, 2019
• Global Infectious Disease Research Training Program
  Application deadline: July 25, 2019
• U.S.-South Africa Program for Collaborative Biomedical Research Phase 2
  HIV/AIDS (R01 Clinical Trial Optional) (RFA-AI-19-022) and (U01 Clinical Trial Optional) (RFA-AI-19-023)
  Infectious Diseases (R01 Clinical Trial Optional) (RFA-AI-19-024) and (U01 Clinical Trial Optional) (RFA-AI-19-025)
  Application deadline: July 26, 2019
• Fogarty HIV Research Training Program
  Application deadline: August 20, 2019
• Global Brain and Nervous System Disorders Research Across the Lifespan
  Application deadline: November 7, 2019
• Emerging Global Leader Award
  Application deadline: November 7, 2019
• Chronic, Noncommunicable Diseases and Disorders Research Training
  Application deadline: November 12, 2019
• Ecology and Evolution of Infectious Diseases (EEID)
  Application deadline: November 20, 2019